Skip to main content
CSTL
NASDAQ Life Sciences

Castle Biosciences' AdvanceAD-Tx Shows 97.8% Concordance in Atopic Dermatitis Study

Tom Rudovsky · Reported by Wiseek News
More coverage: Diagnostics & Research Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$28.65
Mkt Cap
$812.539M
52W Low
$14.59
52W High
$44.28
52W Position info
96% above low
Off High info
35% below high
Rel. Volume info
1.8× avg
Market data snapshot near publication time

CSTL sits 96% above its 52-week low of $14.59.

Summary

A new study shows Castle's AdvanceAD-Tx test led to 97.8% pathway-concordant systemic therapy decisions for atopic dermatitis, nearly doubling the 54.3% baseline. This follows yesterday's Q2 revenue beat and raised guidance, adding a clinical validation catalyst. The data strengthens the test's reimbursement and adoption case in a growing market. No specific upcoming event to watch.

At the time of this announcement, CSTL was trading at $28.65 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $812.5M. The 52-week trading range was $14.59 to $44.28. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Wiseek News.


Price Chart

Share this article

Copied!

CSTL - Latest Insights

CSTL
Nov 05, 2026, 4:05 PM EST
Source: PR Newswire
Importance Score:
8
Price at Filing: $34.20
Real-time Price: $33.25 info
Change: -$0.955 (-3%) info
Market Cap: $1.022B info
CSTL
Jul 30, 2026, 4:15 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $27.99
Real-time Price: $33.25 info
Change: +$5.25 (+19%) info
Market Cap: $1.022B info
CSTL
Jul 30, 2026, 4:09 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $28.48
Real-time Price: $33.25 info
Change: +$4.76 (+17%) info
Market Cap: $1.022B info
CSTL
Jul 30, 2026, 4:06 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $28.83
Real-time Price: $33.25 info
Change: +$4.41 (+15%) info
Market Cap: $1.022B info
CSTL
May 06, 2026, 4:09 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $24.60
Real-time Price: $33.25 info
Change: +$8.64 (+35%) info
Market Cap: $1.022B info